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The mouse vomeronasal organ (VNO) expresses chemosensory receptors that detect
intra-species as well as inter-species cues. The vomeronasal neurons are thought to be
highly selective in their responses. The tuning properties of individual receptors remain
difficult to characterize due to the lack of a robust heterologous expression system. Here,
we take a transgenic approach to ectopically express two type 1 vomeronasal receptors
in the mouse VNO and characterize their responses to steroid compounds. We find that
V1rj2 and V1rj3 are sensitive to two sulfated estrogens (SEs) and can be activated by a
broad variety of sulfated and glucuronidated steroids at high concentrations. Individual
neurons exhibit narrow range of concentration-dependent activation. Collectively, a
neuronal population expressing the same receptor covers a wide dynamic range in their
responses to SEs. These properties recapitulate the response profiles of endogenous
neurons to SEs.
Keywords: vomeronasal receptor, calcium imaging, sulfated steroids, transgenic mice, glucuronidated steroid,
GCaMP2
Introduction
Terrestrial animals emit pheromones for intra-species chemo-communication. Within the
same species, pheromones convey information about sexual, social, and reproductive status
of individuals. They trigger a restricted repertoire of innate and stereotyped behaviors,
including mating rituals, territorial aggression, and neuroendocrine responses (Wyatt, 2003). The
vomeronasal organ (VNO) plays an important role for detecting pheromones in most terrestrial
vertebrate species (Halpern and Martinez-Marcos, 2003; Swaney and Keverne, 2009). The mouse
VNO expresses about 400 seven-transmembrane G protein-coupled receptors including the type 1
vomeronasal receptors (V1Rs), type 2 vomeronasal receptors (V2Rs), and formyl peptide receptors
(Dulac and Axel, 1995; Herrada and Dulac, 1997; Matsunami and Buck, 1997; Ryba and Tirindelli,
1997; Young and Trask, 2007; Liberles et al., 2009; Riviere et al., 2009; Young et al., 2010). Each
vomeronasal sensory neuron (VSN) expresses either a single member of V1R or FPR, or a specific
pair of V2R genes (Ibarra-Soria et al., 2014; Liberles, 2014). These receptors are dedicated to detect
a variety of chemosensory cues and transmit the signal to the brain.
In natural environment, pheromone cues are present in bodily secretion and excretion, such
as tears, feces, and urine (Ihara et al., 2013). The chemical nature of the pheromones ranges
from volatile and non-volatile small molecular weight compounds to peptides and proteins
(Novotny et al., 1985, 1986; Jemiolo et al., 1989; Leinders-Zufall et al., 2004; Kimoto et al.,
2005; Chamero et al., 2007; Nodari et al., 2008; Riviere et al., 2009; Haga et al., 2010; Roberts
et al., 2010, 2012; Ferrero et al., 2013). A unique pumping mechanism is required to bring the
pheromone cues into the vomeronasal cavity where they are in contact with the dendrites of VSNs
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(Meredith et al., 1980; Meredith, 1994). In addition to their
chemical identities, pheromone concentrations also convey
specific information (He et al., 2010; Ihara et al., 2013).
The vomeronasal system is able to detect cues at various
concentrations and convey concentration-invariant signals to the
brain (Arnson and Holy, 2013).
VSNs are able to detect pheromone cues with high sensitivity
and selectivity. In some studies, VSNs can respond specifically to
ligands at sub-nanomolar concentrations (Leinders-Zufall et al.,
2000, 2004, 2014; Kimoto et al., 2005; He et al., 2010; Isogai et al.,
2011; Haga-Yamanaka et al., 2014). It is not understood how the
VSN achieve a balance between receptor sensitivity and a wide
dynamic range of detection. There are two plausible mechanisms
that can be considered. In one scenario, neurons expressing the
same receptor may exhibit different sensitivities to accommodate
a wide range of ligand concentrations. Alternatively, neurons
expressing different receptors with distinct sensitivities to the
ligand broadens the detectable range of pheromones. Current
available data do not distinguish these two hypotheses.
Thus, in order to understand the mechanisms of pheromone
tuning, it is important to characterize the specific interactions
between pheromones and their cognate receptors. However, after
nearly 20 years of cloning of the first V1Rs, we have limited
understanding of the receptor characteristics and functions. The
main obstacle is the lack of a robust heterologous expression
system that enables functional analysis of VR responses. In
an earlier study, we overcome this challenge by generating
transgenic mice that ectopically express V1Rs in VSNs (Haga-
Yamanaka et al., 2014). The ectopic expression of vomeronasal
receptors in their native environment enables us to identify
V1rj2 and V1rj3 receptors as the cognate receptors for sulfated
estrogens (SEs). In the current study, we further characterize
the response profiles of V1rj2 and V1rj3 receptors to a panel of
sulfated and glucuronidated steroids.
Materials and Methods
Mice
All mice were maintained in Lab Animal Service Facility
of Stowers Institute at 12:12 light/dark cycle and provided
with food and water ad libitum. Experimental protocols were
approved by the Institutional Animal Care and Use Committee
at Stowers Institute and in compliance with NIH Guide for Care
and Use of Animals. OMP-IRES-tTA (OIVT), Gγ8-tTA, tetO-
GCaMP2, tetO-V1rj2-IRES-tdTomato, and tetO-V1rj3-IRES-
tdTomato mice were described previously (Yu et al., 2004;
Nguyen et al., 2007; He et al., 2008; Haga-Yamanaka et al., 2014).
Mice containing OIVT, Gγ8-tTA, and tetO-GCaMP2 alleles were
used to assess the wild type responses. Compound heterozygotic
mice that contained tetO-V1rj2-IRES-tdTomato and tetO-V1rj3-
IRES-tdTomato were generated to assess the V1rj2 and V1rj3
responses, respectively. VNO slices were prepared from 2 to 6
months old male and female mice.
Chemicals
Sulfated and glucuronidated steroids were purchased from
Steraloids (Newport, RI, USA), and the catalog IDs were used
to label the compounds. We dissolved the steroids in dimethyl
sulfoxide (DMSO) to make 20mM stock solutions, which were
further diluted in Ringer’s solution (in mM: 125 NaCl, 2.5 KCl, 2
CaCl2, 2 MgCl2, 25 NaHCO3, 10 HEPES, and 10 glucose) to the
testing concentrations.
Calcium Imaging of VNO Slices
Details of imaging setup and procedures were described
previously (Ma et al., 2011). Briefly, VNO slices were
maintained in carboxygenated (95% O2, 5% CO2) mouse
artificial cerebrospinal fluid (mACSF; in mM: 125 NaCl, 2.5
KCl, 1 MgCl2, 2 CaCl2, 1.25 NaH2PO4, 25 NaHCO3, and 10
glucose) at room temperature. Carboxygenated mACSF was also
used to superfuse VNO slices at a speed of 1mL/min. The flow
was kept unidirectional by placing the inlet and outlet at the
apical and basal sides of VNO epithelium, respectively. Steroids
were delivered through a HPLC injection valve mounted on
the stage. To minimize mechanical artifacts, a continuous flow
(∼0.3mL/min) of Ringer’s solution was maintained during the
experiment. Solutions were switched by using the injection valve
without disrupting the flow.
Time-lapse imaging acquisition of GCaMP2 signals from
a VNO slice was performed on AxioScope FS2 (Carl Zeiss)
microscope with a 20X/0.5NA water-dipping lens as described
before (He et al., 2008; Ma et al., 2011; Yu, 2013; Haga-Yamanaka
et al., 2014). Intervals between stimuli were at least 3min. When
a robust response to a given chemical was observed, we set the
inter-stimulus interval to 5–10min (varied with response level)
to ensure adequate recovery. Data of individual genotypes or
applications were collected from two to three VNO slices. Image
processing and data analysis, including region of interest (ROI)
detection and automated signal analyses, were performed using
ImageJ and programs written in MATLAB. In order to compute
F, a baseline fitting step was performed to model photo-bleaching
effect and a peak detection step was performed to model the
signal peak. 1F was computed as the difference between the
signal peak and the baseline. The computation was thenmanually
validated to exclude possible errors. A threshold of 30%1F/F was
imposed to identify VSNs as responding to a stimulus. Response
amplitudes were normalized in each individual cell. For ensemble
responses, the dose-response curve was fitted with a sigmoidal
equation and EC50 were calculated using Prism (GraphPad).
Results
VSN Response to Sulfated Estrogens
Two of the SEs, 1, 3, 5(10)-estratrien-3, 17β-diol disulfate
(E1050), and 1, 3, 5(10)-estratrien-3, 17β-diol 17-sulfate (E1103),
strongly activate VSNs and can serve as estrus signals to induce
mounting behaviors in male mice (Haga-Yamanaka et al., 2014).
To understand the dose-dependent activation of VSNs, we
performed Ca2+ imaging experiments using VNO slices from
GCaMP2 mice. We observed VSN responses to E1050 and E1103
at 10−10M in ∼2–4% of cells on a single slice (Figures 1A,B).
The number of responding VSNs increased in a dose-dependent
manner and reached a plateau of approximately 30 cells per
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FIGURE 1 | Activation of VSN by E1050 and E1103. (A)
Representative imaging experiments showing the VSN responses to
E1050 (top) and E1103 (bottom). Scale bar, 50µm. (B) Bar graph
showing the number of VSNs activated by E1050 (red) and E1103 per
slice (blue; n = 3 slices). Error bars, S.E.M. (C) Bar graph showing the
number of E1050- and/or E1103-responding VSNs in 3 slices. Red,
blue, and purple indicate VSNs activated by E1050, E1103, and both
E1050 and E1103, respectively.
slice, which represented approximately 15% of the cell population
(Figures 1A,B).
A comprehensive survey of the VSN response profiles
showed that individual neurons exhibited diverse dose-response
properties and sensitivities to E1050. Some cells showed the
classic sigmoidal dose-response curves with increasing amplitude
as a function of E1050 concentration (Figures 2A,C,D). The
signal plateaued at higher concentrations, which indicated a
saturation of the response. Neurons exhibiting these classic
dose-response curves, however, only represented a fraction
of the total VSNs. We found a large fraction (∼60%) of
neurons displayed bell-shaped curves (Figures 2B–D). The
peak response was reached at an intermediate concentration.
Further increase of ligand concentration led to reduced
response. A few cells displayed dose-response properties
that did not fit either sigmoidal or bell-shaped curves
(Figures 2C,D).
We also observed VSNs displayed different sensitivities
to SE activation (Figure 2D). We used the first response
concentration (FRC) as a measurement of sensitivity. Overall,
the FRCs varied at least four orders of magnitude from 10−10
to 10−7 M. We observed some cells started to respond at
10−7 M, which was the highest concentration tested for these
two SEs. We marked those high-threshold cells as with FRC
at 10−7 M. Regardless of the shape of their dose-response
curves, individual neurons had relatively narrow dynamic ranges.
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FIGURE 2 | Activation of VSN by E1050. (A,B) Examples of sigmoidal (A)
and bell-shaped (B) dose-response curves to E1050. (C) Dose-response
curves of individual cells (gray) and a sigmoidal curve (black) fitted to the
average amplitude from all cells. Error bar, S.E.M. (D) Pie charts showing the
number of cells exhibiting sigmoidal (S, blue), bell-shaped (B, red), and other
(O, green) types of dose responses. Cells with FRC of 10−7 M are shown in
gray. Concentration above each pie chart represents the first response
concentration of the cells.
Approximately 90% of neurons showed the maximal response at
10x FRC.
Although individual neurons had different sensitivities and
narrow dynamic ranges, VSN population can respond to a wide
range of pheromone stimulation collectively (Figure 2C). The
average response to E1050 had an EC50 of 1.921× 10−10Mwith
a dynamic range of 1000 fold change in concentration.
The responses to E1103, a singly-sulfated estrogen compound,
elicited VSN responses at as low as 10−10M (Figures 1A,B).
At this concentration, ∼85% of the neurons activated by
E1103 and E1050 were distinct (Figure 1C). Compared to
E1050, the number of E1103 responding VSNs showed a
slower increase with rising concentration and did not plateau
until 10−8M (Figure 1B). At concentrations higher than 10−9
M, the majority of E1103 responding VSNs overlapped with
E1050 responding cells (Figure 1C). At individual cell level, the
sensitivity ranged across three orders of magnitude. Consistent
with the number of responding VSNs, we found that a large
fraction of the cells showed peak response to E1103 at 10−8
M. Both sigmoidal and bell-shaped dose-response curves were
observed (Figures 3A,B,D). On average, responses to E1103 had
an EC50 of 1.348× 10−9M (Figure 3C).
The bell-shaped dose-response curve also has been observed
in urine-responding VSN neurons (He et al., 2010). Because the
VSNs showed little adaptation to repeated or prolonged stimuli
(Holy et al., 2000; He et al., 2010), it was unlikely that the
diminution of response at high ligand concentration was caused
by cell fatigue or receptor desensitization. To further exclude
these possibilities, we examined the response of individual cells
to different ligands. As shown in Figures 3E,F, the same cell
exhibited reduced response to high concentration (10−7 M) of
E1103, but subsequent application of E1050 nonetheless elicited
strong responses. The same cells, therefore, exhibited distinct
dose-dependent activations to different ligands that was not
related to stimulation sequence.
Activation of V1rj2 by Sulfated Estrogens
In a previous study, we showed that the V1rj clade receptors
respond to SEs by using transgenic mice lines in which V1rj2
and V1rj3 were ectopically expressed (Haga-Yamanaka et al.,
2014). These mice allowed us to further examine the activation
of individual V1rj receptors activated by SEs.
V1rj2-expressing VSNs showed dose-dependent activation
by both SEs (Figures 4, 5). E1050 activated V1rj2-expressing
VSNs at 10−10M and the numbers of responding cells plateaued
at 10−8M (Figure 4B). These VSNs showed both the classic
dose-response curves and bell-shaped curves (Figures 4A,C,E).
In addition, the majority of V1rj2-expressing VSNs started
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FIGURE 3 | Activation of VSN by E1103. (A,B) Examples of sigmoidal
(A) and bell-shaped (B) dose-response curves to E1103. (C)
Dose-response curves of individual cells (gray) and a sigmoidal curve
(black) fitted to the average amplitude from all cells. Error bar, S.E.M. (D)
Pie charts showing the number of cells exhibiting sigmoidal (S, blue),
bell-shaped (B, red) and other (O, green) types of dose responses. Cells
with FRC of 10−7 M are shown in gray. (E,F) Raw traces (left) and
dose-response curves (right) of two representative cells simulated by
E1050 and E1103 in a sequence with increasing concentrations. Arrows
indicate the onset of stimulus delivery.
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FIGURE 4 | Activation of V1rj2 by E1050. (A) Examples of
sigmoidal dose-response curves to E1050 in V1rj2 cells. (B) Bar
graph showing the percentage of E1050 activated V1rj2 cells
(n = 200). (C) Examples of bell-shaped dose- response curves to
E1050 in V1rj2 cells. (D) Dose-response curves of individual cells
(gray) and a sigmoidal curve (black) fitted to the average amplitude
from all cells. Error bar, S.E.M. (E) Pie charts showing the number
of cells exhibiting sigmoidal (S, blue), bell-shaped (B, red), and other
(O, green) types of dose responses. Cells with FRC of 10−7 M are
shown in gray.
responding to E1050 at 10−9M and reached the maximal
response amplitude at 10−8M (Figure 4D). On average, the
V1rj2 neurons covered a dynamic range of 1000 folds
(Figure 4D).
Compared to E1050, fewer V1rj2-expressing VSNs were
activated by E1103 at 10−10M (Figure 5B). Interestingly,
the majority of VSNs exhibited classic dose-response
curves (Figure 5E). Most of V1rj2-expressing VSNs
started to respond at 10−8M and peaked at 10−7M
(Figures 5B,D).
Activation of V1rj3 by Sulfated Estrogens
Compared to V1rj2 cells, VSNs expressing the V1rj3
receptor showed distinct response characteristics to E1050
(Figure 6). The majority of the cells only responded at or
above 10−8M (Figure 6B) and less than 30% of the cells
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FIGURE 5 | Activation of V1rj2 by E1103. (A) Examples of
sigmoidal dose-response curves to E1103 in V1rj2 cells. (B) Bar
graph showing the percentage of E1103 activated V1rj2 cells
(n = 129). (C) Examples of bell-shaped dose-dependent responses of
V1rj2 cells to E1103. (D) Dose-response curves of individual cells
(gray) and a sigmoidal curve (black) fitted to the average amplitude
from all cells. Error bar, S.E.M. (E) Pie charts showing the number
of cells exhibiting sigmoidal (S, blue), bell-shaped (B, red), and other
(O, green) types of dose responses. Cells with FRC of 10−7 M are
shown in gray.
exhibited bell-shaped response curves (Figure 6E). A significant
number of V1rj3-expressing cells were activated by E1050 at
10−10M and showed maximal response at this concentration
(Figure 6D). These populations of VSNs make this single
receptor cover a wide dynamic range in their response to SEs
(Figure 6D).
The V1rj3-expressing cells also responded to E1103 with high
sensitivities (Figure 7). About 50% of the cells responded at
10−10M (Figure 7B). The number of responding cells plateaued
at 10−8 M. Approximately 45% of the cells exhibited bell-shaped
dose-response curves, with the maximal responses elicited
between 10−10 and 10−8M (Figures 7D,E).
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FIGURE 6 | Activation of V1rj3 by E1050. (A) Examples of
sigmoidal dose-response curves to E1050 in V1rj3 cells. (B) Bar
graph showing the percentage of E1050 activated V1rj3 cells
(n = 256). (C) Examples of bell-shaped dose-dependent responses of
V1rj3 cells to E1050. (D) Dose-response curves of individual cells
(gray) and a sigmoidal curve (black) fitted to the average amplitude
from all cells. Error bar, S.E.M. (E) Pie charts showing the number
of cells exhibiting sigmoidal (S, blue), bell-shaped (B, red), and other
(O, green) types of dose responses. Cells with FRC of 10−7 M are
shown in gray.
These results suggested that the V1rj2 receptor was more
sensitive to E1050, while the V1rj3 receptor was more
sensitive to E1103. At the individual cell level, both V1rj2
and V1rj3VSNs exhibited rather narrow dynamic range. The
maximal response was typically observed at a concentration
just 10x of FRC. Collectively, each receptor type was able to
cover the concentration range of SE spanning three orders of
magnitude.
Activation of V1rj2 Receptor by Glucuronidated
Estrogens
Steroid hormones can be modified after initial synthesis
and during circulation. Circulating estrogen molecules
are modified by specific enzymes to become sulfated or
glucuronidated estrogens (GEs), which are soluble and can be
excreted in urine (Shackleton, 1986; Blair, 2010). We therefore
examined whether GEs also activated the V1rj2 and V1rj3
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FIGURE 7 | Activation of V1rj3 by E1103. (A) Examples of
sigmoidal dose-response curves to E1103 in V1rj3 cells. (B) Bar
graph showing the percentage of E1103 activated V1rj3 cells
(n = 256). (C) Examples of bell-shaped dose-dependent responses of
V1rj3 cells to E1103. (D) Dose-response curves of individual cells
(gray) and a sigmoidal curve (black) fitted to the average amplitude
from all cells. Error bar, S.E.M. (E) Pie charts showing the number
of cells exhibiting sigmoidal (S, blue), bell-shaped (B, red), and other
(O, green) types of dose responses. Cells with FRC of 10−7 M are
shown in gray.
receptors using mono-glucuronidated estrogen molecules 1, 3,
5(10)-estratrien- 3, 17β -diol 3-glucosiduronate (E1072) and 1, 3,
5(10)-estratrien-3, 17β- diol 17-glucosiduronate (E1073). The 3-
and 17-hydroxyl groups are glucuronidated in E1072 and E1073,
respectively.
At 10−7 M, E1072 stimulated responses in V1rj2 cells
(Figures 8A,B). The response amplitude was comparable to
that activated by E1050 and E1103 at the same concentration.
On the other hand, E1073 did not induce any response
in V1rj2 expressing VSNs at concentrations up to 10−5M
(Figures 8A–C). Dose-response analysis indicated that
V1rj2 cells were highly sensitive to E1072. Neurons were
activated at 10−10M and reached the maximal response at
10−9M (Figure 8G). These cells also showed narrow dynamic
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FIGURE 8 | Activation of V1rj2 and V1rj3 by Glucuronidated
Estrogens. (A) Representative imaging experiments showing the responses
of V1rj2 cells to vehicle control, E1050, E1103, E1072, and E1073 at 10−7
M. Scale bar, 50µm. (B) Bar graph showing the normalized response to
E1050, E1103, E1072, and E1073 in V1rj2 cells at indicated concentration
(n = 409). (C) Bar graph showing the normalized response to E1050, E1103,
E1072, and E1073 in V1rj2 cells at indicated concentrations (n = 409). (D)
Representative imaging experiments showing the responses of V1rj3 cells to
vehicle control, E1050, E1103, E1072, and E1073 at 10−7 M. (E) Bar graph
showing the normalized response to E1050, E1103, E1072, and E1073 in
V1rj3 cells at indicated concentration (n = 204). (F) Bar graph showing the
normalized response to E1050, E1103, E1072, and E1073 in V1rj3 cells at
indicated concentrations (n = 318). (G,H) Dose-response curve of V1rj2 (G)
and V1rj3 (H) cells activated by E1072. Error bars, S.E.M.
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ranges. Similar to the SEs, we observed bell-shaped dose-
response curves that peaked at concentrations between 10−9
and 10−7 M. In contrast, V1rj3-expressing VSNs did not
respond to E1072 or E1073 more than the vehicle controls
(Figures 8D–F,H). These results demonstrated that E1072
was a ligand for V1rj2 and E1073 could not activate either
receptors.
Responses of V1rj2 and V1rj3 to Other Sulfated
Steroids
Previous studies have shown that individual VSNs are activated
by different steroid compounds (Nodari et al., 2008; Meeks
et al., 2010; Isogai et al., 2011). We also observed that V1rj2
expressing VSNs responded to a sulfated androgen, 5-androsten-
3β, 17β-diol-disulfate (A7864), and other members of SEs, such
as 17β-estradiol 3-sulfate (E1100) (Haga-Yamanaka et al., 2014).
Here, we analyzed the response of V1rj2 and V1rj3 to these
two compounds. Approximately 80% of V1rj2 expressing VSNs
began to respond to both A7864 and E1100 at 10−7 M. The
response amplitude plateaued at 10−7M and increasing ligand
concentration did not further augment the response amplitude
(Figure 9A). A7864 and E1100 were able to activate V1rj3 at
10−5M (Figure 9B).
To obtain a comprehensive understanding of ligand selectivity
of these V1R receptors, we tested a panel of sulfated steroids at
10−5M(Figures 9C,D). V1rj2 expressing VSNs were activated by
multiple sulfated androgens including A2398, A2534, A7864, and
A8530. They also responded to a couple of sulfated progesterones
including P2135 and P3865, a corticosterone, Q5545, and all the
SEs tested including E0588, E0893, and E1100 (Figure 9C). V1rj3
cells were more selective in their responses. They were activated
by a couple of sulfated androgens, A2398 and A7864, sulfated
progesterone, P2135, and one SE, E1100 (Figure 9D). V1rj3 cell
did not respond to sulfated corticosterone stimulation. Thus,
V1rj2 and V1rj3 receptors were activated by a diverse group
of sulfated steroids and showed tuning preference to different
compounds.
Structural Basis of V1rj2 and V1rj3 Activation
The two V1rj receptors share 81% amino acid sequence similarity
but exhibit differential tuning and dose-response relationship
to steroid derivatives. By comparing the molecular structures
of the sulfated and glucuronidated steroids, it appears that
a core estradiol-17β structure is essential for highly sensitive
activation of the receptors (Figure 10). The 3- and 17β-
hydroxyl groups appear to be important structural determinants.
The steroid compounds maintain high potency when the 3-
hydroxyl group is unmodified, sulfated or glucuronidated.
However, compounds with a ketone group at this position,
such as A6940, lose their ability to activate the receptors.
The β configuration of the 17-hydroxyl group is important,
too. E0893, which has α configuration, is two orders of
magnitude less potent in activating the V1rj2 receptor than E0588
and E1100. This observation suggests that the configuration
at the 17-β site plays an important role in activating the
receptors. Glucuronidation at this site, as in E1073, blocks
its activity, whereas the native or sulfated form retains
activity.
We observe that the most potent compounds possess an
unsaturated A ring, but permutations in this structure appear to
be tolerated (Figure 10C). Compounds that possess unsaturated
A ring, 18-methyl group or unsaturated bonds in the B ring
activate the receptors as long as the 3 and 17β-hydroxyl groups
are intact.
Discussion
By taking advantage of a transgenic system to ectopically express
the V1Rs, we circumvent a major obstacle in characterizing
vomeronasal receptors. Although the VRs can be expressed
in heterologous systems, the receptors are retained in the
endoplasmic reticulum and cannot be transported to the cell
surface. Chaperone proteins, including receptor-transporting
proteins (RTPs) and receptor expression enhancing proteins
(REEPs), have been shown to facilitate transportation of some
odorant receptors to the cell membrane (Saito et al., 2004;
Mainland and Matsunami, 2012). None of these molecules
can facilitate the surface expression of V1Rs. Although several
molecules have been reported to be involved in VR surface
expression, it is still challenging to examine individual VR
function in heterologous expression systems (Ishii et al., 2003;
Loconto et al., 2003; Dey and Matsunami, 2011). In our
transgenic system, individual VRs can be ectopically expressed
via a synthetic tetO promoter and transported to the cell
surface utilizing the endogenous chaperons in VSNs. Thus,
this system allows us to characterize VR response in its native
environment.
Recapitulation of Native Responses
Previously we observed a diverse responses of VSNs to urinary
pheromone stimulation (He et al., 2008, 2010). It was not clear
whether the variations in responses arose from the mixture
of pheromone cues in the urine or from diverse properties
of the VSNs. In the transgenic lines, we also observe that
the VSNs display a variety of dose-dependent activation by
individual pheromone ligands. Sensitivities of individual cells to
SEs range from sub-nanomolar to -micromolar concentrations.
The overall dynamic range of the response of the two receptors
are comparable to that of the endogenous receptors to SE ligands.
Individual V1rj2 or V1rj3 expressing neurons show both
sigmoidal and bell-shaped dose-response curves, similar to
those observed in wild type VSNs. Different dose-response
relationships appear to be specific to individual cells. We notice
that a smaller percentage of V1rj2 and V1rj3 cells exhibit bell-
shaped dose-response curves than the wild type VSNs. The
difference may reflect the level of expression of receptor proteins
in the transgenic mice, which may affect the coupling between
receptor and downstream signaling pathways. Alternatively, the
dose-response properties may be intrinsic to individual cells.
As the V1rj receptors are expressed in most of the VSNs
in the transgenic line, the difference in cellular properties
may affect how the ectopically expressed receptors respond to
ligands.
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FIGURE 9 | Activation of V1rj2 and V1rj3 by Other Sulfated Steroids.
(A) Dose-response curves of V1rj2 cells activated by A7864 (n = 201) and
E1100 (n = 199). (B) Dose-response curves of V1rj3 cells activated by
A7864 (n = 249) and E1100 (n = 249). (C,D) Bar graphs showing the
normalized response of V1rj2 (C; n = 183) and V1rj3 (D; n = 373) cells a
panel of sulfated steroid compounds. Error bars, S.E.M.
The cellular mechanism that generates the bell-shaped
dose-response curves is unknown. Experimental evidence
from multiple studies suggests that they are unlikely the
result of receptor desensitization or cell fatigue. Calcium
signal is usually correlated with spiking activity. When
a cell is stimulated by a high concentration of ligand, it
is possible that a large depolarization inactivates voltage-
gated sodium and calcium channels such that the cell
cannot sustain action potentials and Ca2+ entry through
the Ca2+ channels. As voltage-gated channels can recover
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FIGURE 10 | Structural elements of steroid compounds that activate
V1rj2 and V1rj3 receptors. (A) Steroid compounds that activate V1rj2 and
V1rj3 receptors. The minimal concentrations of activation are indicated. (B)
Molecular structures of sulfated or glucuronidated steroids that induce no or
weak responses. (C) Schematic illustration of important structural elements
required to activate the V1rj2 and V1rj3 receptors. The estradiol backbone
(yellow) and 17-β hydroxyl group (pink) are highlighted. Structural
permutations that are permissible are indicated by arrows in the right panel.
quickly from refractory period, this scenario could
explain why the cells can respond to different ligands
differently at high concentrations. Our result puts the
focus on this phenomenon, and further analyses using
electrophysiological recording could reveal the cellular
mechanism.
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Sensitivity and Dynamic Range of the VSNs
The ectopically expressed V1rj receptors are activated by SEs
at concentrations as low as 10−10 M. It appears that more
V1rj3 cells respond to the ligands at this low concentration than
V1rj2 cells. The majority of the cells show response saturation
within two orders of magnitude. An efficient intracellular signal
amplification process is likely to couple the response. The VNO
has unusual signal transduction mechanisms (Kim et al., 2012).
Different signaling cascades could allow low concentration of
ligands to elicit a neuronal response to achieve heightened
sensitivity. An amplification process may also explain the
relatively narrow dynamic range at individual cell level. A
relatively moderate increase in ligand concentration may quickly
saturate the responses. In some cells, overstimulation may cause
desensitization, which can result in a decline of responses
as shown in the bell-shaped dose-response curves to steroid
compounds and to mouse urine (He et al., 2010).
VSNs expressing the same receptor exhibit different
sensitivities. Since each cell also display sharp changes in
dose-dependent activation, the sensitivity is unlikely to reflect
differences in intrinsic amplification. It is more likely that
sensitivity is determined by the amount of receptors expressed
on the cell surface. Alternatively, the binding affinity of the VNO
receptors might be affected by the membrane environment in
which they are expressed. Our current study, however, does not
have evidence to fully address this question.
Despite the narrow dynamic range of individual cells,
the VSN population respond to a wide range of ligand
concentrations. The average dose-response curve spans at least
three orders of magnitude. This allows the VNO to accommodate
a large quantitative variation of pheromones presented by
animals. VSNs expressing the same vomeronasal receptor project
stereotypically to multiple glomeruli in the accessory olfactory
bulb (Belluscio et al., 1999; Rodriguez et al., 1999; Wagner
et al., 2006; Haga et al., 2010; Ishii and Mombaerts, 2011).
Each glomerulus likely receives input from VSNs expressing the
same VR. This convergence pattern may allow each glomerulus
to integrate signals transmitted by neurons with disparate
sensitivity such that the glomerulus serves as a proxy of the
VSN collectives. Alternatively, it is also possible that VSN
axons segregate in their projection patterns according to ligand
sensitivity such that each of the multiple glomeruli exhibits
narrow concentration tuning. This scenario may provide a
mechanism to readout concentration ratios for concentration-
invariant perception of the pheromone cues. Detailed study of
the glomerular responses in the AOBwould distinguish these two
models.
Our study also shows that neurons expressing the same
receptor could be tuned to different steroid compounds at high
concentrations. Therefore, in addition to chemical identities of
ligands, concentration information about a ligand could also be
transmitted by different receptors.
Tuning Specificity and Steric Configuration of the
Molecules
V1rj2 and V1rj3 are sensitive to SE compounds. They are also
activated to a lesser extent by other sulfated and glucuronidated
steroids. The structural determinants of the activation appear to
require the 3- and 17-hydroxyl groups and estradiol backbone.
V1rj3 appears to be more sensitive to SEs, but are also tuned
to fewer compounds than V1rj2. The specific interaction of
these structural elements with the receptors may determine the
specificity and sensitivity of V1rj2 and V1rj3 receptors. The
structure basis that differentiates these two receptors remains
unknown.
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